A Multicohort Study of Toripalimab in Combination With Investigator-Selected Chemotherapy for Advanced HER2-Negative Breast Cancer
Clinical trial NCT07540533 · RECRUITING
Trial details
- NCT number
- NCT07540533
- Sponsor
- Henan Cancer Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-20
- Primary completion
- 2027-08-01
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.